Joslyn S Kirby, MD, FAAD
SESSIONS
F013 How to Approach Challenges in Hidradenitis Suppurativa Management: Strategies to Optimize Use of HS Therapies
Mar 8, 2024
•
9:00 AM - 11:00 AM
•
Room 1B
S017 Great Care for Common Conditions: Combining Evidence and Cost Effectiveness
Mar 8, 2024
•
1:00 PM - 4:00 PM
•
Room 2
DISCLOSURES
AbbVie – Speaker(Honoraria); Incyte Corporation – Employee (w-2 relationship)(Salary); Novartis – Consultant(Fees); Penn State University – Other(Patent royalties or other compensation for Intellectual Property Rights); UCB – Consultant(Fees);